-
1
-
2
-
3
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
Published 2019-07-01Get full text
Article -
4
-
5
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
Published 2022-05-01Get full text
Article -
6
-
7
-
8
-
9
-
10
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
Published 2021-07-01Get full text
Article -
11
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
Published 2020-06-01Get full text
Article -
12
Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular Subtype
Published 2023-03-01Get full text
Article -
13
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Published 2022-03-01Get full text
Article -
14
-
15
-
16
-
17
Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements
Published 2023-02-01Get full text
Article -
18
PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?
Published 2020-05-01Get full text
Article -
19
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
Published 2019-07-01Get full text
Article -
20
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
Published 2022-09-01Get full text
Article